Determination of the Red Cell Distribution Width, NT-proBNP and cTnT in Acute Myocardial Infarction Patients
NCT ID: NCT05677503
Last Updated: 2023-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2023-01-15
2023-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Red Cell Distribution Width,,NT-proBNP and cTnT in Acute Myocardial Infraction Patient
NCT05595278
Association Between Peri-procedural Myocardial Injury and Quantitative Blood Flow Ratio
NCT07110298
Distribution of Highly Sensitive Troponin in the Critically Unwell & Associated Mortality
NCT03630237
Using Higher Cut-off Values to Diagnose Acute Myocardial Infarction in Patients With Elevated Hs-cTnT Concentrations
NCT06059079
Quantification and Description of the Increase in Serum Troponin Following Acute Coronary Syndrome
NCT01698021
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Type of study: Observational prospective study
* Place of study: Sohag cardiology and gastroenterology center, department of cardiology and cardiac care unit.
* Ethical considerations: This research will be revised by the Scientific Ethical Committee of Sohag University Hospital. Consents will be taken from all patients.
* Study Methods:
* A prospective study on 30 patients diagnosed as acute myocardial infarction on which measurement of CBC, serum NT-proBNP, and cTnT levels will be performed at the time of admission and by the time of discharge.
1. Full history:
1. Personal history: e.g. age, sex and smoking.
2. Family history of cardiac diseases
3. Medical history of: Hypertension, Ischemic heart disease, prior coronary artery bypass grafting, Prior Percutaneous coronary intervention, Prior Stroke, Prior Atrial fibrillation, therapeutic history
2. Detailed clinical examination
3. Electrocardiogram
4. Laboratory investigation:
1. Routine investigation in the form of CBC including RDW
2. Specific investigation which include NT-proBNP and cTnT
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBC
measurement of CBC will be performed at the time of admission and by the time of discharge
(NT-proBNP)
measurement of serum NT-proBNP levels will be performed at the time of admission and by the time of discharge
(cTnT)
measurement of cTnT levels will be performed at the time of admission and by the time of discharge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Decompensated heart failure
* Pulmonary hypertention
* Acute pulmonary embolism
* Septic shock
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hemat Kamel Maarouf
Resident doctor at clinical and chemical pathology department
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sohag_Med_22_12_07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.